Loss of UK genetics public bodies confirmed

15 October 2010

The effect of these changes is likely to hinge significantly on the nature and remit of regulatory functions as devolved between existing and new regulators. It is not clear that financial savings will be made in the short term, though the Government says the moves will increase transparency and accountability. However, the capacity of public bodies to examine issues relating to genetics and medicine will certainly be reduced.

More from us

Genomics and policy news